American Association of Equine Practitioners (AAEP) Board Votes to Support the Horseracing Integrity and Safety Act
On the recommendation of its Racing Committee, the American Association of Equine Practitioners board of directors voted this week to support the Horseracing Integrity and Safety Act (H.R.1754/S.4547). The legislation’s chief goal is to create uniform safety and medication standards in all U.S. racing jurisdictions. “Uniformity of rules is essential to protecting the safety of the racehorse and ensuring the integrity of the sport,” said AAEP President Dr. David Frisbie.
However, for the horse to be best served, the AAEP will continue to advocate for additional veterinary representation on the HISA board and committees beyond the single position currently designated for each. “In the previous version of the bill, the AAEP was a strong proponent for the governance structure to include individuals with the requisite expertise needed to capably address anti-doping and therapeutic medication regulation,” said Dr. Jeff Berk, AAEP immediate past president and Racing Committee chair. “The composition of the Authority Nominating Committee gives us confidence that the needed scientific expertise for these important positions will be considered, but we believe the breadth of knowledge needed to successfully protect equine athletes requires additional individuals.”
Position on Lasix:
Regarding the race-day administration of furosemide (Lasix), the AAEP’s position continues as one of support, as the medication remains the most efficacious treatment for exercise-induced pulmonary hemorrhage (EIPH) in the horse. However, in 2019, a coalition of 20 racetracks, including hosts of Triple Crown races, along with numerous racing jurisdictions committed to restricting administration of furosemide on race day, independent of federal legislation .
“We are pleased to see in the revised legislation that the Authority will convene an advisory panel comprised of horse racing anti-doping and medication control experts to study race-day furosemide, including its impact on equine health and the integrity of competition,” added Dr. Scott Hay, AAEP president-elect and a racetrack practitioner. “Investigating effective management strategies for EIPH which do not require race-day medication administration has been a central goal of the AAEP’s Prescription for Racing Reform developed five years ago.”
Today, September 29, 2020, the Horseracing Integrity and Safety Act (H.R.1754) was unanimously passed the U.S. House of Representatives. Led by Congressman Andy Barr (D-KY) and Congressman Paul Tonko (D-NY), this landmark legislation will create an independent regulatory authority responsible for establishing uniform safety and competition standards for horse racing. The bill now heads to the U.S. Senate, where Senate Majority Leader Mitch McConnell (R-KY) and Senators Feinstein (D-CA), Gillibrand (D-NY) and McSally (R-AZ), are leading the effort for its passage.
The Horseracing Integrity and Safety Act, H.R.1754/S.4547, will recognize the newly formed Horseracing Integrity and Safety Authority (HISA), which will be tasked with creating uniform, national standards regarding prohibited and permitted substances for use in horses, setting up an accreditation system for labs to test drug samples, and developing regional standards regarding racetrack safety.
“With today’s HISA passage in the House, we continue our momentum and move one step closer toward historic reform for the horse racing industry,” said Congressman Barr. “This legislation, developed through a highly deliberative and bipartisan process, will ensure the safety of our equine athletes and increase the popularity, public confidence, and international competitiveness of the sport."
“After nearly six years working to advance this bipartisan legislation to modernize horseracing in the United States, we are at long last rounding the final turn,” Congressman Tonko said. “Our Horseracing Integrity and Safety Act puts the health and well-being of our equine athletes and jockeys firmly at the center of the sport, and delivers commonsense medication and track safety standards that will lift this noble sport to higher standards of integrity and safety."
93% Want Congressional Action on a National Anti-Doping & Safety Program
WASHINGTON, D.C. – Concern about racehorse safety and equine drug and safety issues among the public is sky high according to a new survey by Xenophon Analytics in Washington, D.C. The survey was conducted by polling a national database of people aware or interested in horse racing and issues impacting the industry.
In the survey, 78% of people were aware of the 2019 spike in equine fatalities, 61% were very aware of controversy over the use of medications in the horse racing industry with 83% believing that the problem was widespread and systematic.
It should receive widespread support considering that poll respondents supported a national system of equine medication control over the present system of separate state regulations by 95% to 5%.
The poll also showed strong support (94%) for racetrack safety programs, including the adoption of a national racetrack safety standards program and race-day and out-of-competition drug testing (93%).
“Sixty-nine percent of the people surveyed had a negative perception of the horse racing industry,” continued Fuscus. “But 67% also stated that their view would be improved by industrywide reforms related to anti-doping and equine safety.”
Xenophon Analytics’ Horse Racing Survey was taken nationally with a size of 3,116 respondents. The survey was conducted from Aug. 20, 2020, through Aug. 25, 2020, and has a margin of error of +/- 2%. The poll and data can be viewed on Xenophon’s website.
MONTH / yEAR